Global Cord Blood (NYSE:CO) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report released on Wednesday morning. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

NYSE:CO opened at $1.30 on Wednesday. The company’s 50-day simple moving average is $1.59 and its 200-day simple moving average is $1.40. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50. The stock has a market capitalization of $158.02 million, a P/E ratio of 2.03 and a beta of 0.16.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.